In a report released yesterday, Steven Valiquette from Barclays maintained a Buy rating on Align Tech (ALGN), with a price target of $305.00. The company’s shares closed last Monday at $262.89.
According to TipRanks.com, Valiquette is a 4-star analyst with an average return of 4.0% and a 53.5% success rate. Valiquette covers the Services sector, focusing on stocks such as Capital Senior Living, Patterson Companies, and AmerisourceBergen.
The word on The Street in general, suggests a Strong Buy analyst consensus rating for Align Tech with a $298.57 average price target, representing a 20.0% upside. In a report released yesterday, Piper Sandler also maintained a Buy rating on the stock with a $275.00 price target.
See today’s analyst top recommended stocks >>
Align Tech’s market cap is currently $20.72B and has a P/E ratio of 47.54. The company has a Price to Book ratio of 15.87.
Based on the recent corporate insider activity of 59 insiders, corporate insider sentiment is negative on the stock. This means that over the past quarter there has been an increase of insiders selling their shares of ALGN in relation to earlier this year.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Align Technology, Inc. engages in the manufacture, design, and marketing of global medical devices. It operates through the Clear Aligner, and Scanner and Services segments. The Clear Aligner segment consists of invisalign full, teen and assist products, and vivera retainers along with training and ancillary products for treating malocclusion.
